191 related articles for article (PubMed ID: 24214218)
1. Overview of current standpoints in profiling of circulating tumor cells.
Kim K; Lee KH; Lee J; Choi J
Arch Pharm Res; 2014 Jan; 37(1):88-95. PubMed ID: 24214218
[TBL] [Abstract][Full Text] [Related]
2. Circulating tumor cells: a multifunctional biomarker.
Yap TA; Lorente D; Omlin A; Olmos D; de Bono JS
Clin Cancer Res; 2014 May; 20(10):2553-68. PubMed ID: 24831278
[TBL] [Abstract][Full Text] [Related]
3. Isolation of rare circulating tumor cells in cancer patients: technical aspects and clinical implications.
Danova M; Torchio M; Mazzini G
Expert Rev Mol Diagn; 2011 Jun; 11(5):473-85. PubMed ID: 21707456
[TBL] [Abstract][Full Text] [Related]
4. Towards a personalized breast cancer treatment approach guided by circulating tumor cell (CTC) characteristics.
Onstenk W; Gratama JW; Foekens JA; Sleijfer S
Cancer Treat Rev; 2013 Nov; 39(7):691-700. PubMed ID: 23683721
[TBL] [Abstract][Full Text] [Related]
5. Controversies in circulating tumor cell count during therapy.
Raimondi C; Gradilone A; Gazzaniga P
Expert Rev Mol Diagn; 2013 Jun; 13(5):499-507. PubMed ID: 23782256
[TBL] [Abstract][Full Text] [Related]
6. Circulating tumor cells as promising novel biomarkers in solid cancers.
Lianidou ES; Strati A; Markou A
Crit Rev Clin Lab Sci; 2014 Jun; 51(3):160-71. PubMed ID: 24641350
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer.
Hou JM; Krebs MG; Lancashire L; Sloane R; Backen A; Swain RK; Priest LJ; Greystoke A; Zhou C; Morris K; Ward T; Blackhall FH; Dive C
J Clin Oncol; 2012 Feb; 30(5):525-32. PubMed ID: 22253462
[TBL] [Abstract][Full Text] [Related]
8. Advanced technologies for studying circulating tumor cells at the protein level.
Chan CM; Au TC; Chan AT; Ma BB; Tsui NB; Ng SS; Hui EP; Chan LW; Ho WS; Yung BY; Wong SC
Expert Rev Proteomics; 2013 Dec; 10(6):579-89. PubMed ID: 24206230
[TBL] [Abstract][Full Text] [Related]
9. Detection and Enumeration of Circulating Tumor Cells with Invasive Phenotype.
Wang H; Wu X
Adv Exp Med Biol; 2017; 994():133-141. PubMed ID: 28560672
[TBL] [Abstract][Full Text] [Related]
10. Organ-specific markers in circulating tumor cell screening: an early indicator of metastasis-capable malignancy.
Paterlini-Bréchot P
Future Oncol; 2011 Jul; 7(7):849-71. PubMed ID: 21732757
[TBL] [Abstract][Full Text] [Related]
11. Development of a molecular multimarker assay for the analysis of circulating tumor cells in adenocarcinoma patients.
de Albuquerque A; Kubisch I; Ernst D; Breier G; Stamminger G; Fersis N; Stölzel U; Boese-Landgraf J; Eichler A; Kaul S
Clin Lab; 2012; 58(5-6):373-84. PubMed ID: 22783565
[TBL] [Abstract][Full Text] [Related]
12. [Circulating tumor cells: liquid biopsy].
Alix-Panabières C; Pierga JY
Bull Cancer; 2014 Jan; 101(1):17-23. PubMed ID: 24445939
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of circulating tumor cells (CTCs) in newly-diagnosed and recurrent ovarian cancer patients.
Liu JF; Kindelberger D; Doyle C; Lowe A; Barry WT; Matulonis UA
Gynecol Oncol; 2013 Nov; 131(2):352-6. PubMed ID: 23954902
[TBL] [Abstract][Full Text] [Related]
14. Biologic challenges in the detection of circulating tumor cells.
Joosse SA; Pantel K
Cancer Res; 2013 Jan; 73(1):8-11. PubMed ID: 23271724
[TBL] [Abstract][Full Text] [Related]
15. Circulating tumour cells, their role in metastasis and their clinical utility in lung cancer.
O'Flaherty JD; Gray S; Richard D; Fennell D; O'Leary JJ; Blackhall FH; O'Byrne KJ
Lung Cancer; 2012 Apr; 76(1):19-25. PubMed ID: 22209049
[TBL] [Abstract][Full Text] [Related]
16. New frontiers in circulating tumor cell analysis: A reference guide for biomolecular profiling toward translational clinical use.
Becker TM; Caixeiro NJ; Lim SH; Tognela A; Kienzle N; Scott KF; Spring KJ; de Souza P
Int J Cancer; 2014 Jun; 134(11):2523-33. PubMed ID: 24122526
[TBL] [Abstract][Full Text] [Related]
17. Microfluidics and circulating tumor cells.
Dong Y; Skelley AM; Merdek KD; Sprott KM; Jiang C; Pierceall WE; Lin J; Stocum M; Carney WP; Smirnov DA
J Mol Diagn; 2013 Mar; 15(2):149-57. PubMed ID: 23266318
[TBL] [Abstract][Full Text] [Related]
18. Prognostic role and HER2 expression of circulating tumor cells in peripheral blood of patients prior to radical cystectomy: a prospective study.
Rink M; Chun FK; Dahlem R; Soave A; Minner S; Hansen J; Stoupiec M; Coith C; Kluth LA; Ahyai SA; Friedrich MG; Shariat SF; Fisch M; Pantel K; Riethdorf S
Eur Urol; 2012 Apr; 61(4):810-7. PubMed ID: 22277196
[TBL] [Abstract][Full Text] [Related]
19. Circulating tumor cells as a predictive biomarker in patients with hormone-sensitive prostate cancer.
Goodman OB; Symanowski JT; Loudyi A; Fink LM; Ward DC; Vogelzang NJ
Clin Genitourin Cancer; 2011 Sep; 9(1):31-8. PubMed ID: 21705286
[TBL] [Abstract][Full Text] [Related]
20. Circulating tumor cells in lung cancer.
Young R; Pailler E; Billiot F; Drusch F; Barthelemy A; Oulhen M; Besse B; Soria JC; Farace F; Vielh P
Acta Cytol; 2012; 56(6):655-60. PubMed ID: 23207444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
